Article Text

Download PDFPDF
Response to Endovascular treatment of 113 cavernous carotid aneurysms (J NeuroIntervent Surg 2010;2:359)
  1. Jonathan Hartman
  1. Correspondence to Dr Jonathan Hartman, Kaiser Permanente Sacramento Medical Center, Sacramento, CA 95825, USA; jonathan.hartman{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

When I first saw the title of the article by Choulakian, Drazin and Alexander1 in the December 2010 JNIS, I thought that I had misread it. Indeed, who has experience treating over 100 cavernous carotid aneurysms (CCAs)? I went on to read, with dismay, the description of treatment of what most commonly should be regarded as ‘do not touch’ lesions. In the authors' defense, three of the 113 patients treated did present with subarachnoid hemorrhage (SAH), and these clearly merit treatment. Regarding the 29 patients presenting with diplopia, one could debate whether treatment is necessary or even helpful; the authors cite articles on the subject but fail to mention that in …

View Full Text


  • Provenance and peer review Not commissioned; internally peer reviewed